Mayo Clinic researchers have tested a new approach to treating blood cancer by administering single massive doses of the measles vaccine to two patients, one of whom achieved remission in the proof-of-concept study. Multiple myeloma tumors are vulnerable to the measles virus, and the trial showed that the viral components of the vaccine were effective against cancer cells. In the study, the patients received enough vaccine for 10 million inoculations.
Huge dose of measles vaccine treats woman's blood cancer in trial
SmartBrief Job Listings for Health Care
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan